Esej o The Future of Anti-Doping: Gene Doping and Biological Passports - 237 slow

The Genetic Frontier

The landscape of athletic enhancement is shifting from exogenous chemical substances toward the direct manipulation of the human genome. Gene doping involves the non-therapeutic use of gene-transfer technology to augment physical performance: specifically by altering cellular functions to increase oxygen uptake, accelerate recovery, or amplify muscle mass. Unlike traditional synthetic drugs, these modifications occur within the athlete’s own genetic architecture, making detection through standard blood or urine analysis exceptionally difficult. This molecular frontier represents a profound challenge for regulatory bodies, as the distinction between natural genetic variation and artificial intervention becomes increasingly blurred. As CRISPR and other gene-editing tools become more accessible, the risk of permanent physiological alteration grows, necessitating a complete overhaul of traditional testing protocols.

Longitudinal Surveillance

• 100 slow
• 250 slow
• 1000 slow
• 2000 slow